Syncona : Full Year Results for the 12 months ended 31 March 2023

Syncona Ltd, a leading healthcare company focused on creating, building and scaling a portfolio of global leaders in life science, today announces its Annual Results for the 12 months ended... | June 15, 2023

Related Keywords

Chris Hollowood ,Astrazeneca ,Syncona Ltd ,Advisory Group ,Syncona Investment Management ,Annual Results ,Beacon Therapeutics ,Interim Results ,Autolu Nucleus ,Beacon Therapeutic ,X Linked Retinitis Pigmentosa ,Swanbio Therapeutics ,Syncona Investment Management Limited ,Syncona Limited Stock Exchange ,News ,Information ,Press Release ,Syncona ,Reading ,Healthcare ,Company ,Ocused ,N ,Building ,End ,Scaling ,Portfolio ,F ,Lobal ,Leaders ,Life ,Oday ,Nnounces ,Its ,Nnual ,Results ,Or ,The ,2 ,Onths Bact Gg00b8p59c08 ,